Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread

Annals of Thoracic Surgery

Volumn 97, Issue 4, 2014, Pages 1156-1162

  Legras, Antoine ^a   Mordant, Pierre ^a   Arame, Alex ^a   Foucault, Christophe ^a   Dujon, Antoine ^b   Le Pimpec Barthes, Françoise ^a   Riquet, Marc ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Cedar Surgical Centre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; LUNG NON SMALL CELL CANCER; LYMPH FLOW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84898597817     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.12.047     Document Type: Article

References (31)

1. K.S. Albain, R.S. Swann, and V.W. Rusch et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
2. M.M. Kirsh, D.R. Kahn, and O. Gago et al. Treatment of bronchogenic carcinoma with mediastinal metastases Ann Thorac Surg 12 1971 11 21
3. H.I. Libshitz, R.J. McKenna Jr., and C.F. Mountain Patterns of mediastinal metastases in bronchogenic carcinoma Chest 90 1986 229 232
4. P. Misthos, E. Sepsas, K. Athanassiadi, S. Kakaris, and I. Skottis Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer Eur J Cardiothorac Surg 25 2004 502 508
5. K.L. Prenzel, S.P. Mönig, and J.M. Sinning et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer J Surg Oncol 82 2003 256 260
6. M. Riquet, J. Assouad, P. Bagan, C. Foucault, F. Le Pimpec Barthes, A. Dujon, and C. Danel Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis Ann Thorac Surg 79 2005 225 233
7. American Joint Committee on Cancer (AJCC) cancer staging Handbook. From the AJCC Cancer Staging Manual, seventh edition. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A III, eds. Chicago: Springer; 2010;299-323.
8. C.F. Mountain, and C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723
9. N. Martini Mediastinal lymph node dissection for lung cancer. The Memorial experience Chest Surg Clin N Am 5 1995 189 203
10. F. Kwiatkowski, M. Girard, K. Hacene, and J. Berlie Sem: a suitable statistical software adaptated for research in oncology [Article in French] Bull Cancer 87 2000 715 721
11. Y. Funakoshi, Y. Takeuchi, H. Kusumoto, T. Kimura, and H. Maeda Which subgroup of patients with pathologic N2 non-small cell lung cancer benefit from surgery? J Cancer Res Clin Oncol 138 2012 1027 1033
12. M. Riquet, D. Manac'h, M. Saab, F. Le Pimpec-Barthes, A. Dujon, and B. Debesse Factors determining survival in resected N2 lung cancer Eur J Cardiothorac Surg 9 1995 300 304
13. S.M. Keller, M.G. Vangel, and H. Wagner et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J Thorac Cardiovasc Surg 128 2004 130 137
14. C. Casali, A. Stefani, P. Natali, G. Rossi, and U. Morandi Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases Eur J Cardiothorac Surg 28 2005 33 38
15. M. Riquet, P. Bagan, and F. Le Pimpec Barthes et al. Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases Ann Thorac Surg 84 2007 1818 1824
16. P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer Ann Thorac Surg 86 2008 1626 1630
17. G.B. Ratto, R. Costa, P. Maineri, A. Alloisio, P. Bruzzi, and B. Dozin Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection? J Thorac Cardiovasc Surg 138 2009 849 858
18. H. Decaluwé, P. De Leyn, and J. Vansteenkiste et al. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival Eur J Cardiothorac Surg 36 2009 433 439
19. T. Nakagiri, N. Sawabata, and S. Funaki et al. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer Interact Cardiovasc Thorac Surg 12 2011 733 738
20. N. Martini, B.J. Flehinger, M.B. Zaman, and E.J. Beattie Jr. Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases Ann Surg 198 1983 386 397
21. M. Riquet, G. Hidden, and B. Debesse Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults J Thorac Cardiovasc Surg 97 1989 623 632
22. M. Riquet Bronchial arteries and lymphatics of the lung Thorac Surg Clin 7 2007 619 638
23. K. Pantel, R.J. Cote, and O. Fodstad Detection and clinical importance of micrometastatic disease J Natl Cancer Inst 91 1999 1113 1124
24. M. Riquet, D. Manac'h, F. Le Pimpec-Barthes, A. Dujon, and A. Chehab Prognostic significance of surgical-pathologic N1 disease in non-small-cell carcinoma of the lung Ann Thorac Surg 67 1999 1572 1576
25. M. Riquet Anatomic basis of lymphatic spread from carcinoma of the lung to the mediastinum: surgical and prognostic implications Surg Radiol Anat 15 1993 271 277
26. A. Christiansen, and M. Detmar Lymphangionesis and cancer Genes cancer 2 2011 1146 1158
27. F. Aloisi, and R. Pujol-Borrell Lymphoid neogenesis in chronic inflammatory diseases Nat Rev Immunol 6 2006 205 217
28. PORT Meta-analysis Trialists Group Postoperative radiotherapy for non-small cell lung cancer Cochrane Database Syst Rev 2005 CD002142
29. S.A. Carrillo, V.C. Daniel, N. Hall, C.L. Hitchcock, P. Ross Jr., and E.S. Kassis Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer Ann Thorac Surg 93 2012 1621 1624
30. H. Vesselle, J.M. Pugsley, E. Vallières, and D.E. Wood The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer J Thorac Cardiovasc Surg 124 2002 511 519
31. P. De Leyn, P. Dooms, and J. Kuzdzal et al. Revised ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer Eur J Cardiothorac Surg 2013 [In press]